Most Empagliflozin side effects are mild, dose-related and settle as treatment continues. The reactions that matter clinically are rare but need to be recognised quickly.
Key takeaways
- Common effects: genital mycotic infection, volume depletion, rare ketoacidosis.
- Avoid Empagliflozin in type 1 diabetes and recurrent genital infections.
- Dose-related effects often resolve by stepping back one strength.
- Severe or persistent reactions warrant stopping and seeking review.
Frequency bands
| Frequency | Reactions | Action |
|---|---|---|
| Very common (>10%) | genital mycotic infection, volume depletion | Usually self-limiting; supportive measures and reassurance. |
| Common (1–10%) | rare ketoacidosis | Review dose and timing; consider dose reduction. |
| Uncommon (<1%) | hypersensitivity, marked laboratory changes | Stop and arrange clinical assessment. |
| Rare | serious organ-specific reactions | Stop immediately; urgent medical attention. |
Reducing the burden
Take Empagliflozin exactly as directed: 10 mg once daily in the morning, increased to 25 mg. Splitting titration into smaller steps, dosing with food where the label allows, and hydrating well cover most tolerability problems seen in practice.
Empagliflozin at a glance
| Attribute | Detail |
|---|---|
| Drug class | SGLT2 inhibitor |
| Common brand | Jardiance |
| Licensed use | type 2 diabetes, heart failure and CKD |
| Available strengths | 10 mg, 25 mg |
| Dosage form | film-coated tablet |
| Typical onset | glucosuria within 24 hours, HbA1c effect over 12 weeks |
| Duration / dosing interval | 24-hour dosing |
| Storage | below 30 °C |
